Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Charles Daley

Concepts (430)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Mycobacterium Infections, Nontuberculous
75
2022
279
15.610
Why?
Mycobacterium avium Complex
36
2022
87
7.200
Why?
Mycobacterium abscessus
27
2022
79
6.950
Why?
Mycobacterium avium-intracellulare Infection
23
2022
60
6.920
Why?
Antitubercular Agents
37
2021
165
6.570
Why?
Tuberculosis
31
2021
246
6.080
Why?
Lung Diseases
37
2022
725
6.070
Why?
Nontuberculous Mycobacteria
41
2022
161
5.800
Why?
Tuberculosis, Pulmonary
25
2021
127
5.290
Why?
Anti-Bacterial Agents
49
2022
1366
4.930
Why?
Tuberculosis, Multidrug-Resistant
12
2019
45
4.150
Why?
Mycobacterium Infections
12
2019
64
4.040
Why?
Mycobacterium kansasii
10
2020
15
3.700
Why?
Mycobacterium tuberculosis
26
2019
281
3.350
Why?
Mycobacterium
13
2019
91
3.000
Why?
Bronchiectasis
15
2020
96
2.660
Why?
Amikacin
12
2021
17
2.640
Why?
Macrolides
14
2021
63
2.640
Why?
Cystic Fibrosis
16
2022
913
2.430
Why?
Interferon-gamma Release Tests
6
2016
27
2.300
Why?
Drug Resistance, Bacterial
19
2021
154
2.160
Why?
Sputum
25
2020
287
1.950
Why?
Latent Tuberculosis
8
2017
65
1.560
Why?
Pneumonia, Bacterial
6
2017
104
1.530
Why?
AIDS-Related Opportunistic Infections
4
2016
119
1.440
Why?
Clofazimine
4
2021
15
1.370
Why?
Antibiotics, Antitubercular
9
2021
37
1.370
Why?
Humans
168
2022
114571
1.310
Why?
Rifampin
13
2021
74
1.280
Why?
Pneumonia
4
2021
559
1.120
Why?
Clarithromycin
12
2021
29
1.100
Why?
HIV Infections
15
2022
2498
1.080
Why?
Oxazolidinones
3
2013
14
1.070
Why?
Acetamides
3
2013
30
1.060
Why?
Global Health
8
2018
346
1.020
Why?
Ethambutol
10
2021
21
1.010
Why?
Disease Outbreaks
5
2019
291
0.940
Why?
Tuberculin Test
6
2016
35
0.930
Why?
Microbial Sensitivity Tests
17
2021
296
0.910
Why?
Equipment Contamination
2
2019
51
0.900
Why?
Drug Therapy, Combination
18
2021
1004
0.890
Why?
Aged
52
2021
20218
0.860
Why?
Professional Practice Gaps
1
2020
10
0.850
Why?
Middle Aged
59
2021
28854
0.770
Why?
Treatment Outcome
29
2020
9190
0.760
Why?
Disease Management
4
2021
605
0.750
Why?
San Francisco
10
2014
49
0.730
Why?
Molecular Epidemiology
4
2006
58
0.710
Why?
Male
74
2022
60817
0.650
Why?
Female
73
2021
63070
0.640
Why?
Adult
48
2022
32077
0.640
Why?
Health Care Sector
2
2013
32
0.620
Why?
Extensively Drug-Resistant Tuberculosis
2
2013
6
0.620
Why?
Retrospective Studies
28
2022
11642
0.610
Why?
Drug Resistance, Multiple, Bacterial
4
2019
64
0.610
Why?
Phylogeny
5
2021
730
0.600
Why?
Azithromycin
6
2021
84
0.600
Why?
Genome, Bacterial
5
2021
103
0.580
Why?
Linezolid
4
2018
15
0.560
Why?
Lung
14
2022
3558
0.540
Why?
United States
29
2021
12551
0.520
Why?
Communicable Disease Control
1
2014
69
0.500
Why?
Sex Factors
1
2019
1971
0.490
Why?
Serologic Tests
1
2012
58
0.480
Why?
Professional Practice
1
2012
67
0.470
Why?
Rifabutin
2
2012
6
0.450
Why?
Antibiotic Prophylaxis
1
2012
91
0.450
Why?
Opportunistic Infections
1
2011
53
0.450
Why?
Practice Guidelines as Topic
6
2015
1541
0.440
Why?
Pyrazinamide
4
2021
11
0.440
Why?
Occupational Health
1
2013
211
0.410
Why?
Recurrence
10
2019
988
0.400
Why?
Mass Screening
3
2016
1066
0.400
Why?
Occupational Exposure
1
2013
312
0.390
Why?
Cardiac Surgical Procedures
3
2019
474
0.390
Why?
Administration, Inhalation
6
2021
667
0.380
Why?
Aged, 80 and over
14
2021
6818
0.370
Why?
Incidence
10
2019
2454
0.370
Why?
Health Personnel
3
2014
515
0.340
Why?
Antigens, Bacterial
5
2012
129
0.340
Why?
Directly Observed Therapy
2
2005
14
0.340
Why?
Drug Administration Schedule
7
2020
808
0.340
Why?
Carcinoma, Squamous Cell
1
2012
555
0.330
Why?
Organ Transplantation
1
2009
160
0.330
Why?
Tuberculosis, Pleural
2
2003
6
0.330
Why?
Tomography, X-Ray Computed
9
2020
2379
0.320
Why?
Morbidity
2
2019
268
0.320
Why?
Genomics
4
2021
514
0.310
Why?
Diarylquinolines
2
2019
7
0.300
Why?
ROC Curve
4
2020
489
0.290
Why?
World Health Organization
2
2018
114
0.290
Why?
Antibodies, Monoclonal
1
2012
1294
0.290
Why?
Disease Progression
6
2020
2486
0.290
Why?
Diagnostic Tests, Routine
2
2019
91
0.290
Why?
Mutation
5
2019
3378
0.280
Why?
Disease Transmission, Infectious
1
2005
64
0.280
Why?
Water Microbiology
1
2005
75
0.270
Why?
Drug Synergism
3
2021
360
0.270
Why?
DNA Fingerprinting
1
2004
25
0.270
Why?
Risk Factors
9
2019
9078
0.270
Why?
Contact Tracing
1
2004
27
0.270
Why?
Alveolitis, Extrinsic Allergic
1
2005
78
0.270
Why?
DNA, Bacterial
3
2021
300
0.260
Why?
Self Administration
1
2004
130
0.260
Why?
Biomedical Research
5
2020
585
0.260
Why?
Biomarkers
3
2020
3485
0.260
Why?
Prospective Studies
13
2021
6288
0.260
Why?
Research
2
2018
464
0.250
Why?
Pneumonectomy
2
2016
125
0.250
Why?
Republic of Korea
6
2019
26
0.240
Why?
Registries
5
2020
1915
0.240
Why?
Adolescent
17
2021
18658
0.240
Why?
Isoniazid
4
2019
51
0.230
Why?
Administration, Oral
3
2020
796
0.230
Why?
Lung Neoplasms
2
2012
2191
0.230
Why?
Spectinomycin
1
2021
3
0.230
Why?
Thorax
1
2022
47
0.230
Why?
Radiography, Thoracic
3
2017
179
0.220
Why?
Cohort Studies
8
2020
5000
0.220
Why?
Bacteriophages
1
2022
62
0.220
Why?
Comorbidity
4
2019
1645
0.210
Why?
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
1
2020
5
0.210
Why?
Oxazepines
1
2020
4
0.210
Why?
Peptidyl Transferases
1
2020
5
0.210
Why?
Serine Proteases
1
2020
16
0.210
Why?
Safety
1
2003
327
0.210
Why?
Benzoxazoles
1
2020
23
0.210
Why?
Respiratory Therapy
1
2020
18
0.210
Why?
Cluster Analysis
4
2020
467
0.210
Why?
Time Factors
7
2020
7029
0.210
Why?
Prevalence
4
2019
2393
0.210
Why?
Young Adult
10
2019
10987
0.210
Why?
Nitroimidazoles
1
2019
6
0.200
Why?
Imipenem
4
2021
16
0.200
Why?
Mycobacterium fortuitum
1
2019
2
0.200
Why?
Area Under Curve
3
2020
319
0.200
Why?
Oxazoles
1
2019
31
0.190
Why?
Durable Medical Equipment
1
2019
3
0.190
Why?
Genotyping Techniques
1
2019
73
0.190
Why?
Follow-Up Studies
5
2020
4950
0.190
Why?
Cost of Illness
1
2021
296
0.190
Why?
Anti-HIV Agents
3
2016
688
0.180
Why?
Drug-Related Side Effects and Adverse Reactions
1
2021
230
0.180
Why?
DNA Gyrase
1
2018
12
0.180
Why?
Patient Selection
1
2003
707
0.180
Why?
Tertiary Care Centers
1
2019
129
0.180
Why?
Bronchoscopy
1
2020
242
0.180
Why?
Aza Compounds
2
2010
13
0.180
Why?
Respiratory System Agents
1
2018
16
0.180
Why?
Musculoskeletal Diseases
1
2019
66
0.180
Why?
Genotype
6
2019
1848
0.180
Why?
Internationality
1
2019
155
0.180
Why?
Treatment Failure
3
2019
334
0.170
Why?
Dose-Response Relationship, Drug
3
2020
2187
0.170
Why?
Tuberculosis Vaccines
2
2010
8
0.170
Why?
Quality of Life
3
2018
2230
0.170
Why?
Patient Compliance
3
2011
609
0.170
Why?
Biological Specimen Banks
1
2018
64
0.170
Why?
Liposomes
1
2018
169
0.170
Why?
Elephants
1
2017
3
0.170
Why?
alpha 1-Antitrypsin Deficiency
1
2018
77
0.170
Why?
Salvage Therapy
1
2018
139
0.170
Why?
Forced Expiratory Volume
5
2020
550
0.170
Why?
Databases, Genetic
1
2018
171
0.170
Why?
Agammaglobulinemia
1
2017
33
0.170
Why?
Fluoroquinolones
3
2018
42
0.160
Why?
Quinolines
2
2010
140
0.160
Why?
Pulmonary Medicine
1
2018
84
0.160
Why?
Kartagener Syndrome
1
2016
23
0.160
Why?
Staphylococcal Infections
2
2018
323
0.160
Why?
Surgical Equipment
1
2016
13
0.160
Why?
Child
10
2021
17859
0.160
Why?
Interferon-gamma
4
2007
771
0.160
Why?
Prognosis
5
2020
3546
0.160
Why?
Sensitivity and Specificity
4
2020
1920
0.150
Why?
Levofloxacin
1
2016
24
0.150
Why?
Surgical Wound Infection
1
2019
225
0.150
Why?
Immunologic Deficiency Syndromes
1
2016
82
0.150
Why?
Genes, Bacterial
1
2016
162
0.150
Why?
Public Health
4
2016
442
0.150
Why?
Adrenal Cortex Hormones
1
2019
510
0.150
Why?
Gene Expression Profiling
2
2020
1561
0.140
Why?
Patient Outcome Assessment
1
2016
121
0.140
Why?
Clinical Trials as Topic
3
2020
1004
0.140
Why?
Computational Biology
1
2018
473
0.140
Why?
Gene Expression Regulation
2
2020
2555
0.140
Why?
DNA Transposable Elements
2
2006
83
0.140
Why?
Drug Tolerance
1
2015
152
0.140
Why?
Cross Infection
1
2016
203
0.130
Why?
Guidelines as Topic
1
2016
291
0.130
Why?
Sequence Analysis, DNA
2
2014
734
0.130
Why?
Patient Acceptance of Health Care
2
2018
671
0.130
Why?
Genetic Variation
2
2021
824
0.130
Why?
Antiretroviral Therapy, Highly Active
2
2007
277
0.130
Why?
CD4 Lymphocyte Count
2
2004
290
0.130
Why?
MicroRNAs
1
2020
604
0.130
Why?
Transcriptome
2
2015
676
0.130
Why?
Anti-Inflammatory Agents
1
2017
461
0.120
Why?
Societies, Medical
4
2020
764
0.120
Why?
Randomized Controlled Trials as Topic
1
2018
1159
0.120
Why?
Patient-Centered Care
1
2018
485
0.120
Why?
Contraindications
1
2012
96
0.120
Why?
Colorado
4
2022
4488
0.120
Why?
Glycolipids
1
2012
41
0.120
Why?
Consensus
3
2022
458
0.120
Why?
Gene Expression Regulation, Bacterial
1
2015
298
0.120
Why?
Glucocorticoids
1
2017
550
0.120
Why?
Immunoenzyme Techniques
1
2012
224
0.120
Why?
Models, Statistical
1
2016
669
0.110
Why?
Antibodies, Bacterial
1
2012
134
0.110
Why?
Immunoglobulin A
1
2012
149
0.110
Why?
Drug Resistance, Multiple
1
2011
19
0.110
Why?
Cytokines
2
2011
1964
0.110
Why?
Chemical and Drug Induced Liver Injury
2
2003
138
0.110
Why?
Respiratory Tract Infections
1
2014
290
0.110
Why?
Debridement
1
2011
90
0.110
Why?
Metagenomics
2
2021
114
0.110
Why?
Drug Interactions
1
2012
402
0.110
Why?
Virulence
1
2011
237
0.100
Why?
Hospitals, General
2
2014
18
0.100
Why?
Kaplan-Meier Estimate
3
2019
899
0.100
Why?
Case-Control Studies
3
2020
3249
0.100
Why?
Lung Transplantation
1
2012
311
0.100
Why?
Hepatitis, Viral, Human
1
2009
27
0.100
Why?
Bacteriological Techniques
1
2009
62
0.100
Why?
Netherlands
2
2012
73
0.100
Why?
Pulmonary Disease, Chronic Obstructive
2
2018
1209
0.100
Why?
Chronic Disease
2
2018
1648
0.100
Why?
Forkhead Transcription Factors
2
2007
180
0.100
Why?
Hospitalization
1
2018
1714
0.090
Why?
Confidence Intervals
2
2015
337
0.090
Why?
Cough
2
2020
92
0.090
Why?
Interleukins
2
2007
237
0.090
Why?
Child, Preschool
4
2016
9651
0.090
Why?
Vitamins
1
2010
149
0.090
Why?
Proportional Hazards Models
2
2019
1188
0.090
Why?
Early Diagnosis
1
2009
253
0.090
Why?
RNA, Ribosomal, 23S
2
2018
13
0.090
Why?
Interleukin-9
1
2007
11
0.090
Why?
Radiography
2
2008
850
0.090
Why?
Interleukin-12 Subunit p40
1
2007
8
0.080
Why?
Reagent Kits, Diagnostic
1
2007
44
0.080
Why?
Logistic Models
3
2019
2051
0.080
Why?
Pneumonia, Pneumococcal
1
2007
35
0.080
Why?
Double-Blind Method
3
2020
1681
0.080
Why?
Polysaccharides, Bacterial
1
2007
71
0.080
Why?
Survival Analysis
2
2016
1410
0.080
Why?
Polymorphism, Single Nucleotide
3
2021
1744
0.080
Why?
Congresses as Topic
2
2020
202
0.080
Why?
Th1 Cells
1
2007
140
0.080
Why?
Survivors
1
2010
405
0.080
Why?
Vitamin D
1
2010
347
0.080
Why?
Interleukin-8
1
2007
256
0.080
Why?
Liver Function Tests
2
2003
116
0.070
Why?
Coinfection
2
2018
114
0.070
Why?
Age Factors
3
2019
3280
0.070
Why?
Hydrotherapy
1
2005
8
0.070
Why?
Immunosuppressive Agents
1
2009
679
0.070
Why?
Animals
6
2021
34687
0.070
Why?
Antirheumatic Agents
1
2007
254
0.070
Why?
Europe
2
2016
332
0.070
Why?
Surveys and Questionnaires
1
2017
4741
0.070
Why?
Anti-Retroviral Agents
1
2007
191
0.070
Why?
Regression Analysis
1
2008
1109
0.070
Why?
Mycobacterium xenopi
2
2014
4
0.070
Why?
Streptomycin
1
2003
16
0.070
Why?
Respiratory Function Tests
2
2016
590
0.070
Why?
Biopsy
2
2005
1048
0.070
Why?
Cefoxitin
2
2016
10
0.070
Why?
Carrier State
1
2004
57
0.070
Why?
Medicare
2
2019
664
0.070
Why?
Influenza, Human
1
2009
516
0.060
Why?
Pseudomonas Infections
2
2016
188
0.060
Why?
Staphylococcus aureus
2
2018
379
0.060
Why?
Databases, Factual
2
2019
1161
0.060
Why?
Homosexuality, Male
1
2004
168
0.060
Why?
Substance Abuse, Intravenous
1
2004
115
0.060
Why?
Predictive Value of Tests
2
2007
1994
0.060
Why?
Drug Costs
1
2003
96
0.060
Why?
Los Angeles
1
2002
60
0.060
Why?
Mice
3
2021
15429
0.060
Why?
Survival Rate
1
2007
1859
0.060
Why?
Peptidoglycan
1
2021
25
0.060
Why?
Tumor Necrosis Factor-alpha
1
2007
1242
0.060
Why?
Bacterial Proteins
1
2007
770
0.060
Why?
Phenotype
2
2021
2842
0.060
Why?
Lactams
1
2021
38
0.050
Why?
Reproducibility of Results
2
2020
2926
0.050
Why?
Clone Cells
1
2021
253
0.050
Why?
Ambulatory Care
1
2005
461
0.050
Why?
beta-Lactamase Inhibitors
1
2020
2
0.050
Why?
Carboxypeptidases
1
2020
13
0.050
Why?
Azabicyclo Compounds
1
2020
6
0.050
Why?
Cephalosporins
1
2020
24
0.050
Why?
Leukocyte Elastase
1
2020
88
0.050
Why?
Gene Ontology
1
2020
40
0.050
Why?
Real-Time Polymerase Chain Reaction
1
2021
347
0.050
Why?
Chimera
1
2019
60
0.050
Why?
Drug Monitoring
2
2016
189
0.050
Why?
United States Food and Drug Administration
1
2020
185
0.050
Why?
Cross-Over Studies
1
2021
488
0.050
Why?
Multivariate Analysis
1
2003
1600
0.050
Why?
Public Health Surveillance
1
2019
62
0.050
Why?
Meat
1
2019
67
0.050
Why?
Prosthesis-Related Infections
1
2019
70
0.040
Why?
Molecular Diagnostic Techniques
1
2019
97
0.040
Why?
Gene Regulatory Networks
1
2020
206
0.040
Why?
Ribosomal Proteins
1
2018
90
0.040
Why?
Population Surveillance
1
2002
440
0.040
Why?
Mice, Inbred BALB C
1
2021
1315
0.040
Why?
Risk Assessment
2
2019
3208
0.040
Why?
Insurance Claim Review
1
2018
72
0.040
Why?
Symptom Assessment
1
2019
126
0.040
Why?
Animals, Zoo
1
2017
10
0.040
Why?
Methyltransferases
1
2017
63
0.040
Why?
International Cooperation
1
2018
176
0.040
Why?
Otitis
1
2016
3
0.040
Why?
Gene Expression
2
2016
1524
0.040
Why?
Enzyme-Linked Immunosorbent Assay
2
2011
884
0.040
Why?
Pseudomonas
1
2016
27
0.040
Why?
Immunoglobulins
1
2017
141
0.040
Why?
Drug Resistance, Microbial
1
2016
63
0.040
Why?
Micronesia
1
2016
3
0.040
Why?
Mycobacterium chelonae
1
2016
8
0.040
Why?
Vital Capacity
1
2016
249
0.040
Why?
Spirometry
1
2016
288
0.040
Why?
Needs Assessment
1
2018
343
0.040
Why?
Body Temperature Regulation
1
2016
98
0.040
Why?
Host-Pathogen Interactions
1
2019
315
0.040
Why?
Multiple Pulmonary Nodules
1
2016
22
0.040
Why?
Drug Combinations
1
2016
303
0.040
Why?
Injections, Intravenous
1
2016
241
0.040
Why?
Bronchi
1
2017
238
0.040
Why?
Clinical Decision-Making
1
2018
279
0.040
Why?
Rhinitis
1
2016
121
0.040
Why?
Uganda
1
2015
82
0.040
Why?
Leukocytes, Mononuclear
2
2007
489
0.040
Why?
Fibrosis
1
2017
412
0.040
Why?
Sinusitis
1
2016
164
0.030
Why?
Research Design
1
2020
938
0.030
Why?
Insurance, Health
1
2016
263
0.030
Why?
Gastroesophageal Reflux
1
2016
227
0.030
Why?
Sequence Homology, Nucleic Acid
1
2013
166
0.030
Why?
False Positive Reactions
1
2014
124
0.030
Why?
Mycobacterium avium
1
2013
19
0.030
Why?
RNA, Messenger
2
2015
2830
0.030
Why?
Greece
1
2012
4
0.030
Why?
DNA, Ribosomal Spacer
1
2012
6
0.030
Why?
Mycolic Acids
1
2012
8
0.030
Why?
Self Report
1
2017
713
0.030
Why?
Sweden
1
2012
60
0.030
Why?
Bacterial Typing Techniques
1
2012
39
0.030
Why?
Italy
1
2012
94
0.030
Why?
Geography
1
2013
186
0.030
Why?
Iran
1
2012
68
0.030
Why?
Developing Countries
2
2005
249
0.030
Why?
DNA-Directed RNA Polymerases
1
2012
61
0.030
Why?
Cerebrospinal Fluid
1
2012
99
0.030
Why?
Heat-Shock Proteins
1
2012
142
0.030
Why?
Protein Array Analysis
1
2011
63
0.030
Why?
Microspheres
1
2011
106
0.030
Why?
Species Specificity
1
2013
617
0.030
Why?
Referral and Consultation
1
2016
648
0.030
Why?
Pseudomonas aeruginosa
1
2014
290
0.030
Why?
Bone Marrow Cells
1
2012
295
0.030
Why?
Drug Discovery
1
2012
133
0.030
Why?
Body Mass Index
1
2019
2052
0.030
Why?
African Americans
1
2016
963
0.030
Why?
Demography
1
2011
285
0.030
Why?
Postoperative Care
1
2012
237
0.030
Why?
Adaptation, Physiological
1
2015
529
0.030
Why?
Evolution, Molecular
1
2014
416
0.030
Why?
RNA, Ribosomal, 16S
1
2012
473
0.030
Why?
Hepatitis, Chronic
1
2009
5
0.030
Why?
In Vitro Techniques
1
2012
1229
0.020
Why?
Anxiety
1
2016
818
0.020
Why?
Cross-Sectional Studies
2
2014
4408
0.020
Why?
Preoperative Care
1
2012
339
0.020
Why?
Pleural Diseases
1
2009
22
0.020
Why?
Age Distribution
1
2010
396
0.020
Why?
Sex Distribution
1
2010
390
0.020
Why?
Fatty Acids
1
2012
429
0.020
Why?
Vulnerable Populations
1
2009
130
0.020
Why?
Age of Onset
1
2010
479
0.020
Why?
Smoking
1
2016
1584
0.020
Why?
Transcription, Genetic
1
2015
1460
0.020
Why?
Lung Diseases, Interstitial
1
2012
390
0.020
Why?
False Negative Reactions
1
2007
67
0.020
Why?
Depression
1
2016
1186
0.020
Why?
Urinalysis
1
2007
61
0.020
Why?
Lymphatic Diseases
1
2007
17
0.020
Why?
Cystic Fibrosis Transmembrane Conductance Regulator
1
2010
264
0.020
Why?
Molecular Sequence Data
1
2012
3011
0.020
Why?
Continuity of Patient Care
1
2009
280
0.020
Why?
Bone Diseases
1
2007
52
0.020
Why?
Forced Expiratory Flow Rates
1
2006
16
0.020
Why?
Longitudinal Studies
1
2014
2666
0.020
Why?
Africa
1
2006
81
0.020
Why?
Clinical Laboratory Techniques
1
2007
99
0.020
Why?
Infection Control
1
2007
137
0.020
Why?
C-Reactive Protein
1
2007
349
0.020
Why?
India
1
2005
127
0.020
Why?
Skin Diseases
1
2007
152
0.020
Why?
Virus Latency
1
2005
89
0.020
Why?
Wounds and Injuries
1
2012
892
0.020
Why?
Anti-Infective Agents
1
2007
223
0.020
Why?
Up-Regulation
1
2007
942
0.020
Why?
Dendritic Cells
1
2007
488
0.020
Why?
Asthma
1
2016
2039
0.020
Why?
Cost Savings
1
2004
84
0.020
Why?
Quality of Health Care
1
2009
657
0.020
Why?
Diagnostic Techniques, Respiratory System
1
2003
5
0.020
Why?
Pleura
1
2003
23
0.020
Why?
HIV Seronegativity
1
2003
27
0.020
Why?
Costs and Cost Analysis
1
2004
206
0.020
Why?
Pleural Effusion
1
2003
51
0.020
Why?
Infant
1
2016
8096
0.010
Why?
HIV Seropositivity
1
2003
112
0.010
Why?
Mice, Inbred C57BL
1
2012
5137
0.010
Why?
Disease Models, Animal
1
2012
3828
0.010
Why?
Hypertension, Pulmonary
1
2012
1675
0.010
Why?
Severity of Illness Index
1
2010
2847
0.010
Why?
Rural Population
1
2005
467
0.010
Why?
Clinical Protocols
1
2003
246
0.010
Why?
Chi-Square Distribution
1
2003
577
0.010
Why?
Health Policy
1
2004
361
0.010
Why?
Cost-Benefit Analysis
1
2004
554
0.010
Why?
Data Interpretation, Statistical
1
2003
336
0.010
Why?
Models, Theoretical
1
2004
613
0.010
Why?
Liver
1
2002
1832
0.010
Why?
Daley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)